FDA‑Approved Pharmacological Treatments for Disorders in Children and Adolescents
Introduction
Psychiatric and neurodevelopmental disorders in children and adolescents present unique challenges for clinicians. Unlike adults, pediatric patients have ongoing brain and body development, which influences drug absorption, metabolism, and response. While many medications are prescribed “off‑label,” a smaller set of psychotropics have FDA approval (“on label”) for specific pediatric indications. These approvals are based on clinical trials demonstrating safety and efficacy in younger populations. Understanding these treatments is essential for safe prescribing, ethical practice, and effective symptom management.
1. Attention‑Deficit/Hyperactivity Disorder (ADHD)
ADHD is one of the most common pediatric psychiatric disorders. FDA‑approved medications include:
Stimulants (first‑line):
Methylphenidate (Ritalin, Concerta, Metadate, Daytrana patch) – approved for ages 6+.
Dexmethylphenidate (Focalin) – approved for ages 6+.
Amphetamines (Adderall, Vyvanse, Evekeo) – approved for ages 6+.
Non‑stimulants:
Atomoxetine (Strattera) – approved for ages 6+.
Guanfacine ER (Intuniv) – approved for ages 6+.
Clonidine ER (Kapvay) – approved for ages 6+.
Key points:
Stimulants are most effective but require monitoring for appetite suppression, insomnia, and cardiovascular effects.
Non‑stimulants are alternatives for patients with contraindications or poor stimulant tolerance.
2. Depression
Major depressive disorder (MDD) in youth is serious, with risk of suicidality. FDA‑approved medications:
Fluoxetine (Prozac) – approved for ages 8+.
Escitalopram (Lexapro) – approved for ages 12+.
Key points:
Both are SSRIs.
Carry a black box warning for increased risk of suicidal thoughts in youth.
Require close monitoring, especially during initiation.
3. Obsessive‑Compulsive Disorder (OCD)
FDA‑approved medications:
Fluoxetine (Prozac) – approved for ages 7+.
Fluvoxamine (Luvox) – approved for ages 8+.
Sertraline (Zoloft) – approved for ages 6+.
Clomipramine (Anafranil, a TCA) – approved for ages 10+.
Key points:
SSRIs are first‑line due to better safety profile.
Clomipramine is effective but has more side effects (cardiac, anticholinergic).
4. Anxiety Disorders
While few medications are formally approved for pediatric anxiety, SSRIs used for OCD often overlap.
Sertraline, fluoxetine, fluvoxamine – used for generalized anxiety disorder (GAD) and social anxiety (some approvals vary).
Duloxetine (Cymbalta) – approved for GAD in ages 7–17.
5. Bipolar Disorder
FDA‑approved medications:
Lithium – approved for ages 12+.
Risperidone (Risperdal) – approved for ages 10–17 for mania/mixed episodes.
Aripiprazole (Abilify) – approved for ages 10–17.
Quetiapine (Seroquel) – approved for ages 10–17.
Olanzapine (Zyprexa) – approved for ages 13–17.
Key points:
Mood stabilizers and atypical antipsychotics are mainstays.
Monitoring for metabolic side effects and lithium toxicity is essential.
6. Schizophrenia
FDA‑approved medications:
Risperidone – approved for ages 13–17.
Aripiprazole – approved for ages 13–17.
Olanzapine – approved for ages 13–17.
Quetiapine – approved for ages 13–17.
Key points:
Antipsychotics are effective for positive symptoms.
Require monitoring for weight gain, metabolic syndrome, and extrapyramidal symptoms.
7. Autism Spectrum Disorder (ASD)
FDA‑approved medications for irritability associated with ASD:
Risperidone – approved for ages 5–16.
Aripiprazole – approved for ages 6–17.
Key points:
Target aggression, tantrums, and self‑injurious behavior.
Require metabolic monitoring.
8. Other Pediatric Indications
Tourette’s Disorder:
Aripiprazole – approved for ages 6–17.
Haloperidol – older approval, less commonly used due to side effects.
Enuresis (bedwetting):
Imipramine (TCA) – approved but rarely used due to cardiac risks.
Sleep Disorders:
Few FDA approvals; melatonin is widely used off‑label.
9. Safety and Monitoring
Black Box Warnings: SSRIs (suicidality), antipsychotics (metabolic risks).
Baseline labs: CBC, metabolic panel, thyroid, ECG depending on drug.
Ongoing monitoring: Weight, BMI, blood pressure, side effects.
Family education: Essential for adherence and early detection of adverse effects.
10. Clinical Practice Principles
Always start with lowest effective dose.
Combine medication with psychotherapy (CBT, family therapy).
Engage families in shared decision‑making.
Document rationale, especially for off‑label use.
Conclusion
FDA‑approved pharmacological treatments for children and adolescents provide evidence‑based options for ADHD, depression, OCD, anxiety, bipolar disorder, schizophrenia, and autism. While the list is limited compared to adult approvals, these medications form the backbone of pediatric psychopharmacology. Safe prescribing requires careful monitoring, family involvement, and integration with non‑pharmacological interventions.
Quiz: FDA‑Approved Treatments in Children and Adolescents (15 Questions)
Instructions
Select the best answer for each question. Each item is multiple choice.
1. Which stimulant is FDA‑approved for ADHD in children ≥6 years? A. Fluoxetine B. Methylphenidate C. Risperidone D. Lithium Answer: B
2. Which non‑stimulant is FDA‑approved for ADHD? A. Atomoxetine B. Sertraline C. Quetiapine D. Olanzapine Answer: A
3. Which SSRI is FDA‑approved for depression in children ≥8 years? A. Escitalopram B. Fluoxetine C. Paroxetine D. Sertraline Answer: B
4. Which SSRI is FDA‑approved for depression in adolescents ≥12 years? A. Escitalopram B. Fluoxetine C. Sertraline D. Fluvoxamine Answer: A
5. Which SSRI is FDA‑approved for OCD in children ≥6 years? A. Sertraline B. Escitalopram C. Duloxetine D. Paroxetine Answer: A
6. Which TCA is FDA‑approved for OCD in children ≥10 years? A. Imipramine B. Clomipramine C. Amitriptyline D. Nortriptyline Answer: B
7. Which SNRI is FDA‑approved for generalized anxiety disorder in youth? A. Duloxetine B. Venlafaxine C. Desvenlafaxine D. Bupropion Answer: A
8. Which mood stabilizer is FDA‑approved for bipolar disorder in adolescents ≥12 years? A. Lithium B. Valproate C. Lamotrigine D. Carbamazepine Answer: A
9. Which antipsychotic is FDA‑approved for bipolar disorder in ages 10–17? A. Risperidone B. Aripiprazole C. Quetiapine D. All of the above Answer: D
10. Which antipsychotic is FDA‑approved for schizophrenia in adolescents ≥13 years? A. Risperidone B. Aripiprazole C. Olanzapine D. Quetiapine Answer: All of the above
Collepals.com Plagiarism Free Papers
Are you looking for custom essay writing service or even dissertation writing services? Just request for our write my paper service, and we'll match you with the best essay writer in your subject! With an exceptional team of professional academic experts in a wide range of subjects, we can guarantee you an unrivaled quality of custom-written papers.
Get ZERO PLAGIARISM, HUMAN WRITTEN ESSAYS
Why Hire Collepals.com writers to do your paper?
Quality- We are experienced and have access to ample research materials.
We write plagiarism Free Content
Confidential- We never share or sell your personal information to third parties.
Support-Chat with us today! We are always waiting to answer all your questions.
